Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis.

MLA

Gomi, Harumi, et al. “Tokyo Guidelines 2018: Antimicrobial Therapy for Acute Cholangitis and Cholecystitis.” Journal of Hepato-Biliary-Pancreatic Sciences, vol. 25, no. 1, Jan. 2018, pp. 3–16. EBSCOhost, https://doi.org/10.1002/jhbp.518.

APA

Gomi, H., Solomkin, J. S., Schlossberg, D., Okamoto, K., Takada, T., Strasberg, S. M., Ukai, T., Endo, I., Iwashita, Y., Hibi, T., Pitt, H. A., Matsunaga, N., Takamori, Y., Umezawa, A., Asai, K., Suzuki, K., Han, H.-S., Hwang, T.-L., Mori, Y., … Yamamoto, M. (2018). Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis. Journal of Hepato-Biliary-Pancreatic Sciences, 25(1), 3–16. https://doi.org/10.1002/jhbp.518

Chicago

Gomi, Harumi, Joseph S Solomkin, David Schlossberg, Kohji Okamoto, Tadahiro Takada, Steven M Strasberg, Tomohiko Ukai, et al. 2018. “Tokyo Guidelines 2018: Antimicrobial Therapy for Acute Cholangitis and Cholecystitis.” Journal of Hepato-Biliary-Pancreatic Sciences 25 (1): 3–16. doi:10.1002/jhbp.518.